MLAB (Mesa Laboratories) EBITDA per Share: $8.27 (TTM As of Mar. 2026)


MLAB Mesa Laboratories Inc MLAB
77 GF Score
Price $102.42
GF Value $116.05
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Mesa Laboratories EBITDA per Share?

Mesa Laboratories MLAB +4.32% 77 EBITDA per Share is $8.27 as of Mar. 2026. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.05 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 2,032 Hardware companies, Mesa Laboratories ranks better than 57.68% on this metric.

Mesa Laboratories's EBITDA per Share for the three months ended in Mar. 2026 was $1.21. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $8.27.

During the past 12 months, the average EBITDA per Share Growth Rate of Mesa Laboratories was 5.80% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Mesa Laboratories's EBITDA per Share or its related term are showing as below:

MLAB' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -19.4   Med: 11   Max: 96.4
Current: 5.7

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Mesa Laboratories was 96.40% per year. The lowest was -19.40% per year. And the median was 11.00% per year.

MLAB's 3-Year EBITDA Growth Rate is ranked better than
57.68% of 2032 companies
in the Hardware industry
Industry Median: 1.55 vs MLAB: 5.70

Mesa Laboratories's EBITDA for the three months ended in Mar. 2026 was $6.8 Mil.

During the past 12 months, the average EBITDA Growth Rate of Mesa Laboratories was 8.60% per year. During the past 3 years, the average EBITDA Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Mesa Laboratories was 135.10% per year. The lowest was -18.60% per year. And the median was 13.00% per year.


Mesa Laboratories  (NAS:MLAB) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Mesa Laboratories EBITDA per Share Related Terms


Mesa Laboratories EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Mesa Laboratories's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesa Laboratories EBITDA per Share Chart

Mesa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.10 7.00 -44.26 7.81 8.26

Mesa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 2.73 1.94 2.40 1.21
MLAB
77GF Score
Mesa Laboratories Inc MLAB
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mesa Laboratories EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Mesa Laboratories's EBITDA per Share for the fiscal year that ended in Mar. 2026 is calculated as

EBITDA per Share(A: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=45.977/5.565
=8.26

Mesa Laboratories's EBITDA per Share for the quarter that ended in Mar. 2026 is calculated as

EBITDA per Share(Q: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=6.753/5.604
=1.21

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $8.27 mean?
Mesa Laboratories (MLAB) has a EBITDA per Share of $8.27 as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Mesa Laboratories and its competitors. According to the industry distribution chart, Mesa Laboratories ranks #860 out of 2032 companies in the Hardware industry, placing it in the top 42.3%.
Is Mesa Laboratories' EBITDA per Share too high?
Mesa Laboratories' current EBITDA per Share is $8.27. The Hardware industry median EBITDA per Share is 1.55. Mesa Laboratories' value of $8.27 is 433.5% above this industry median. Based on the distribution chart, Mesa Laboratories ranks #860 out of 2032 companies in the Hardware industry, which is above the industry midpoint. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' EBITDA per Share compare to AERG and MVIS?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #860 out of 2032 companies for EBITDA per Share. This puts Mesa Laboratories in the upper half of its industry. The industry median EBITDA per Share is 1.55. Mesa Laboratories' value of $8.27 is 433.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Hardware company?
The median EBITDA per Share among Hardware companies is 1.55, based on 2,032 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current EBITDA per Share of $8.27 is 433.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median EBITDA per Share is 1.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current EBITDA per Share is $8.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.05, compared to a current price of $102.42 — trading 11.7% below its estimated fair value. The current EBITDA per Share is $8.27 and 433.5% above the Hardware industry median of 1.55. Mesa Laboratories' overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current EBITDA per Share is $8.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mesa Laboratories (MLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued. The current stock price of $102.42 is trading 11.7% below its estimated GF Value™ of $116.05. GuruFocus considers Mesa Laboratories to be Modestly Undervalued.

Key valuation signals for MLAB:

  • EBITDA per Share: $8.27
  • GF Value™: $116.05 vs. price of $102.42 (11.7% below fair value)
  • GF Score™: 77/100 with 8 warning signs
  • Industry Position: 433.5% above the Hardware median (#860 of 2032)

No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mesa Laboratories Business Description

Address 12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score

Get the complete analysis for MLAB

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$102.42
Price
$116.05
GF Value